Company news
Nuvo Pharmaceuticals Inc news in 2013
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2013, newest first.
Nuvo Research® and NovaMedica sign agreement to market Pennsaid® in Russia
December 19, 2013
Nuvo Research Announces 2013 Third Quarter Results
October 30, 2013
Nuvo Research® to Receive US$2.0 Million
October 10, 2013
Nuvo Research® Announces Scientific Presentations at Annual Painweek 2013 Meeting
September 5, 2013
Nuvo Research® announces that FDA has accepted Pennsaid® 2% new drug application for review
August 22, 2013
Nuvo Research® announces lawsuit against Mallinckrodt
August 21, 2013
Nuvo announces Mallinckrodt submits PK study report in response to PENNSAID® 2% FDA complete response letter
August 15, 2013
Nuvo Research announces 2013 second quarter results
July 31, 2013
Nuvo Research® announces update to Pennsaid® 2% Complete Response Letter
July 23, 2013
Nuvo Research® and Paladin Labs announce completion of the loan arrangement
July 10, 2013
Galen to acquire U.S. rights for Synera® from Nuvo Research®
July 10, 2013
Nuvo Research Announces Director Election Results of its Annual General Meeting
June 18, 2013
Nuvo Research® and Paladin Labs announce amendment to May 2012 loan arrangement
June 17, 2013
Nuvo Research announces scientific presentations at the Annual Meeting of the American College of Sports Medicine
May 30, 2013
Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of Immunologists
May 16, 2013
Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10
May 14, 2013
Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%
May 9, 2013
Nuvo Research to Complete Share Consolidation
May 7, 2013
Nuvo Research announces 2013 First Quarter Results
May 1, 2013
Nuvo Research announces European launch of Pliaglis® by Galderma
April 23, 2013
Nuvo Research announces scientific presentation at the Annual Meeting of the American Medical Society for Sports Medicine
April 19, 2013
Nuvo Research announces 2012 Fourth Quarter & Year-End Results
March 27, 2013
Nuvo Research provides additional information regarding Pennsaid 2%
March 18, 2013
Nuvo Research announces U.S. launch of Pliaglis® by Galderma
March 11, 2013
Nuvo Research announces FDA response to PENNSAID® 2% NDA
March 5, 2013
Nuvo Research announces settlement agreement with Apotex in PENNSAID® generic litigation
January 29, 2013